These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9434064)

  • 1. Analysis of risk factors for cutaneous warts in renal transplant recipients.
    Barba A; Tessari G; Talamini G; Chieregato GC
    Nephron; 1997; 77(4):422-6. PubMed ID: 9434064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin disease in immunosuppressed patients in relation to epidermal Langerhans' cells.
    Bergfelt L; Larkö O; Blohmé I
    Acta Derm Venereol; 1993 Oct; 73(5):330-4. PubMed ID: 7904395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
    Gjersvik P; Hansen S; Møller B; Leivestad T; Geiran O; Simonsen S; Pfeffer P; Fauchald P
    Transpl Int; 2000; 13 Suppl 1():S380-1. PubMed ID: 11112037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?
    Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Fauchald P
    Transplant Proc; 1999; 31(1-2):1120. PubMed ID: 10083500
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
    Oliveira WRP; Tirico MCCP; Souza AAV; Codarin FR; Silva LLC; Festa Neto C
    Int J Dermatol; 2019 Apr; 58(4):440-448. PubMed ID: 30565651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of seborrhoeic warts with skin cancer in renal transplant recipients.
    Lally A; Casabonne D; Waterboer T; Imko-Walczuk B; Michael KM; Pawlita M; Newton R; Wojnarowska F
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):302-7. PubMed ID: 19732252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine.
    Oka K; Shimodaira H; Hirano T; Sakurai E; Tamaki T; Kozaki M
    Transplantation; 1993 Sep; 56(3):603-9. PubMed ID: 8212155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for cutaneous wart onset in transplant recipients].
    Pruvost C; Penso-Assathiany D; Bachot N; Lang P; Roujeau JC
    Ann Dermatol Venereol; 2002 Mar; 129(3):291-3. PubMed ID: 11988683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of cyclosporine to azathroprine in renal transplant recipients.
    Bassiri A; Amiranssari B; Gol S
    Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy and incidence of de novo cancer in renal transplant recipients.
    Kehinde EO; Petermann A; Morgan JD; Butt ZA; Donnelly PK; Veitch PS; Bell PR
    Br J Surg; 1994 Jul; 81(7):985-6. PubMed ID: 7922092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation.
    Pedersen EB; Hansen HE; Kornerup HJ; Madsen S; Sørensen AW
    Nephrol Dial Transplant; 1993; 8(3):250-4. PubMed ID: 8385294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
    McIntyre HD; Menzies B; Rigby R; Perry-Keene DA; Hawley CM; Hardie IR
    Clin Transplant; 1995 Feb; 9(1):20-4. PubMed ID: 7742578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immune responses in renal transplant recipients treated with cyclosporin and prednisolone with or without azathioprine.
    Wramner L; Mjörnstedt L; Rydberg L; Olausson M
    Scand J Immunol; 1993 Jun; 37(6):656-60. PubMed ID: 8316763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.
    Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP
    Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.